TRALOKINUMAB-LDRM: 4,116 Adverse Event Reports & Safety Profile
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
4,116
Total FAERS Reports
57 (1.4%)
Deaths Reported
239
Hospitalizations
4,116
As Primary/Secondary Suspect
18
Life-Threatening
7
Disabilities
First Report: 03211101 · Latest Report: 20250918
What Are the Most Common TRALOKINUMAB-LDRM Side Effects?
#1 Most Reported
Dermatitis atopic
613 reports (14.9%)
#2 Most Reported
Drug ineffective
461 reports (11.2%)
#3 Most Reported
Pruritus
365 reports (8.9%)
All TRALOKINUMAB-LDRM Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Dermatitis atopic | 613 | 14.9% | 0 | 12 |
| Drug ineffective | 461 | 11.2% | 1 | 5 |
| Pruritus | 365 | 8.9% | 0 | 10 |
| Rash | 266 | 6.5% | 1 | 10 |
| Injection site pain | 206 | 5.0% | 1 | 5 |
| Injection site erythema | 136 | 3.3% | 0 | 1 |
| Dry skin | 135 | 3.3% | 0 | 1 |
| Erythema | 133 | 3.2% | 0 | 3 |
| Eczema | 129 | 3.1% | 0 | 4 |
| Injection site pruritus | 124 | 3.0% | 0 | 1 |
| Injection site swelling | 119 | 2.9% | 0 | 3 |
| Eye pruritus | 106 | 2.6% | 0 | 1 |
| Ocular hyperaemia | 105 | 2.6% | 0 | 0 |
| Urticaria | 97 | 2.4% | 0 | 3 |
| Product use in unapproved indication | 96 | 2.3% | 2 | 11 |
| Conjunctivitis | 95 | 2.3% | 0 | 1 |
| Arthralgia | 91 | 2.2% | 0 | 1 |
| Injection site reaction | 80 | 1.9% | 0 | 1 |
| Skin exfoliation | 80 | 1.9% | 0 | 3 |
| Dry eye | 79 | 1.9% | 0 | 1 |
Who Reports TRALOKINUMAB-LDRM Side Effects? Age & Gender Data
Gender: 61.8% female, 38.2% male. Average age: 50.5 years. Most reports from: US. View detailed demographics →
Is TRALOKINUMAB-LDRM Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2019 | 1 | 0 | 0 |
| 2020 | 1 | 0 | 0 |
| 2021 | 2 | 0 | 1 |
| 2022 | 165 | 2 | 15 |
| 2023 | 205 | 10 | 30 |
| 2024 | 246 | 21 | 41 |
| 2025 | 123 | 10 | 21 |
What Is TRALOKINUMAB-LDRM Used For?
| Indication | Reports |
|---|---|
| Dermatitis atopic | 3,007 |
| Product used for unknown indication | 606 |
| Eczema | 170 |
| Dermatitis | 90 |
| Psoriasis | 55 |
| Neurodermatitis | 46 |
| Dermatitis allergic | 41 |
| Asthma | 17 |
| Pruritus | 16 |
| Dermatitis contact | 10 |
TRALOKINUMAB-LDRM vs Alternatives: Which Is Safer?
TRALOKINUMAB-LDRM vs TRAMADOL
TRALOKINUMAB-LDRM vs TRAMADOL\TRAMADOL
TRALOKINUMAB-LDRM vs TRAMETINIB
TRALOKINUMAB-LDRM vs TRAMETINIB DIMETHYL SULFOXIDE
TRALOKINUMAB-LDRM vs TRANDOLAPRIL
TRALOKINUMAB-LDRM vs TRANDOLAPRIL\VERAPAMIL
TRALOKINUMAB-LDRM vs TRANEXAMIC ACID
TRALOKINUMAB-LDRM vs TRANYLCYPROMINE
TRALOKINUMAB-LDRM vs TRASTUZUMAB
TRALOKINUMAB-LDRM vs TRASTUZUMAB-ANNS
Official FDA Label for TRALOKINUMAB-LDRM
Official prescribing information from the FDA-approved drug label.